8
total announcements
AAREYDRUGS.NS · 15 min delayed
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026, where the Board of Directors considered and approved the Draft of Board Report and its Annexure and Annual Report along with notice for calling the 36th Annual General Meeting of the Company for the Financial Year 31st March 2026.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has published a copy of a newspaper advertisement regarding unaudited financial results for the quarter and three months ended June 30, 2026, and a notice regarding a property dispute.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and the board of directors has approved the results along with a limited review report and MD/CFO certification.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the allotment of 2,520,000 equity shares upon the conversion of 2,500,000 convertible warrants. The warrants were issued on a preferential basis at an offer price of Rs. 63.80 per warrant. The allotment was approved by the Board of Directors on August 6, 2026. The company's issued and paid-up capital will increase to Rs. 33,35,430,000.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended 30th June 2026.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.